Challenge model for Helicobacter pylori infection in human volunteers
Open Access
- 1 September 2004
- Vol. 53 (9) , 1235-1243
- https://doi.org/10.1136/gut.2003.037499
Abstract
Background: A reliable challenge model is needed to evaluate Helicobacter pylori vaccine candidates. Methods: A cag pathogenicity island negative, OipA positive, multiple antibiotic susceptible strain of H pylori obtained from an individual with mild gastritis (Baylor strain 100) was used to challenge volunteers. Volunteers received 40 mg of famotidine at bedtime and 104–1010 cfu of H pylori in beef broth the next morning. Infection was confirmed by 13C urea breath test (13C-UBT), culture, and histology. Eradication therapy was given four or 12 weeks post challenge and eradication was confirmed by at least two separate UBTs, as well as culture and histology. Results: Twenty subjects (nine women and 11 men; aged 23–33 years) received a H pylori challenge. Eighteen (90%) became infected. Mild to moderate dyspeptic symptoms occurred, peaked between days 9 and 12, and resolved. Vomitus from one subject contained >103 viable/ml H pylori. By two weeks post challenge gastric histology showed typical chronic H pylori gastritis with intense acute and chronic inflammation. The density of H pylori (as assessed by cfu/biopsy) was similarly independent of the challenge dose. A minimal infectious dose was not found. Gastric mucosal interleukin 8 levels increased more than 20-fold by two weeks after the challenge. Conclusion: Challenge reliably resulted in H pylori infection. Infection was associated with typical H pylori gastritis with intense polymorphonuclear cell infiltration and interleukin 8 induction in gastric mucosa, despite absence of the cag pathogenicity island. Experimental H pylori infection is one of the viable approaches to evaluate vaccine candidates.Keywords
This publication has 43 references indexed in Scilit:
- New strategies for the prevention and treatment of Helicobacter pylori infectionExpert Opinion on Investigational Drugs, 2002
- Helicobacter pylori in North and South America before ColumbusFEBS Letters, 2002
- Intranasal Immunization with SAG1 and Nontoxic Mutant Heat-Labile Enterotoxins Protects Mice againstToxoplasma gondiiInfection and Immunity, 2001
- Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeysVaccine, 1999
- Natural History of Helicobacter pylori Infection in Childhood: 12‐Year Follow‐up Cohort Study in a Biracial CommunityClinical Infectious Diseases, 1999
- Antimicrobial therapy of peptic ulcersInternational Journal of Antimicrobial Agents, 1997
- Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infectionVaccine, 1997
- Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distributionGastrointestinal Endoscopy, 1994
- Immunisation against gastric infection with Helicobacter species: First step in the prophylaxis of gastric cancer?Zentralblatt für Bakteriologie, 1993
- Experimental Campylobacter jejuni Infection in HumansThe Journal of Infectious Diseases, 1988